Home
お問い合わせ | リヴァノヴァ株式会社

お問い合わせ | リヴァノヴァ株式会社 Market Share Analysis for July 2026

Industry: N/A

Domainlivanova.co.jp

Year Founded--

Employees51 - 200

Annual Revenue--

お問い合わせ | リヴァノヴァ株式会社

お問い合わせ | リヴァノヴァ株式会社 (including company regionals)

livanova.co.jp

See more website traffic and engagement information

Total visits to お問い合わせ | リヴァノヴァ株式会社's top domains

Understand お問い合わせ | リヴァノヴァ株式会社 market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

livanova.co.jp1.7K

See more with Sales Intelligence

Avg. visit duration in お問い合わせ | リヴァノヴァ株式会社's top domains

Analyze お問い合わせ | リヴァノヴァ株式会社 engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

livanova.co.jp00:00:18

See more with Sales Intelligence

Avg. pageviews on お問い合わせ | リヴァノヴァ株式会社's top domains

See how お問い合わせ | リヴァノヴァ株式会社 keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

livanova.co.jp1.38

See more with Sales Intelligence

お問い合わせ | リヴァノヴァ株式会社 top competitors by domain

Top similar sites in July 2026, ranked by their affinity

abiomed.comCompany NameABIOMEDEmployees1001 - 5000HQUnited States, Massachusetts, DanversAnnual revenue> $1BTotal visits18.3KHealth > Health - Other

Top technologies used by お問い合わせ | リヴァノヴァ株式会社

These are the website technologies, by industry, used by お問い合わせ | リヴァノヴァ株式会社 top domains

Widget (3)

Twemoji

Marketing (2)

Google Marketing Platform

Mobile (2)

Meta Viewport

Advertising (1)

PubMatic

More Technologies

6

See all

News & Signals from お問い合わせ | リヴァノヴァ株式会社

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsLivanova launched Essenz Heart-Lung Machine on Mar 1st '23.For Instance, in March 2023, LivaNova, a UK-based manufacturer of medical devices, launched Essenz Heart-Lung Machine, in the US region with a 510(k) clearance from the U.S. Food and Drug Administration.